5 terminated. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Terminated 5 |
| Phase 2 | 1 | Terminated 1 |
Follow Disorders of Sex Development: new trials by email Literature Review of Disorders of Sex Development trials Research Report on Disorders of Sex Development
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1 Abiraterone acetate - Congenital Adrenal Hyperplasia | Phase 1 | Terminated | University of Texas Southwestern Medical Center | 4 | 2017-08-01 | 2025-11-04 |
| GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer Ganetespib, Paclitaxel - Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 1 / Phase 2 | Terminated | Medical University Innsbruck | 133 | 2014-07-04 | 2019-08-13 |
| Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS) Salsalate - Polycystic Ovary Syndrome | Phase 1 | Terminated | Indiana University | 47 | 2012-02-01 | 2017-02-10 |
| Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH) Anastrozole Pill, Testosterone, Placebo Oral Tablet - Hypogonadotropic Hypogonadism, Kallmann Syndrome | Phase 1 | Terminated | Massachusetts General Hospital | 7 | 2010-05-01 | 2017-04-18 |
| Initiating Transdermal Estradiol Therapy in Turner's Syndrome Norditropin, Menostar 14mcg patch, Vivelle dot 25mcg patch - Turner's Syndrome | Phase 1 | Terminated | University of Chicago | 1 | 2009-04-01 | 2014-03-11 |
Adrenal Hyperplasia, Congenital (1) · Carcinoma, Ovarian Epithelial (1) · Fallopian Tube Neoplasms (1) · Hyperandrogenism (1) · Hypogonadism (1) · Idiopathic Hypogonadotropic Hypogonadism (1) · Inflammation (1) · Insulin Resistance (1) · Kallmann Syndrome (1) · Polycystic Ovary Syndrome (1) · Turner Syndrome (1)
Congenital Abnormalities (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Endocrine System Diseases (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Gonadal Disorders (5) · Male Urogenital Diseases (5) · Urogenital Abnormalities (5) · Urogenital Diseases (5) · Genetic Diseases, Inborn (3) · Adnexal Diseases (2) · Adrenogenital Syndrome (2) · Genital Diseases (2) · Genital Diseases, Female (2)
Abiraterone Acetate (1) · Anastrozole (1) · Estradiol (1) · Human Growth Hormone (1) · Paclitaxel (1) · STA 9090 (1) · Testosterone (1) · Transdermal Patch (1) · salicylsalicylic acid (1)
Indiana University (1) · Massachusetts General Hospital (1) · Medical University Innsbruck (1) · University of Chicago (1) · University of Texas Southwestern Medical Center (1)
United States (4) · Austria (1) · Belgium (1) · France (1) · Germany (1)
Nelly Pitteloud, MD (1) · Nicole Concin, MD (1) · Perrin C White, MD (1) · Robert L. Rosenfield, MD (1)
PMID 30590569, PMID 32140727, PMID 32325487
U01HD083493 (1)